BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rai V, Mukherjee S. Targets of immunotherapy for hepatocellular carcinoma: An update. World J Hepatol 2022; 14(1): 140-157 [PMID: 35126844 DOI: 10.4254/wjh.v14.i1.140]
URL: https://www.wjgnet.com/1948-5182/full/v14/i1/140.htm
Number Citing Articles
1
Jun Huang, Chunbei Zhao, Xinhe Zhang, Qiaohui Zhao, Yanting Zhang, Liping Chen, Guifu Dai. Hepatitis B virus pathogenesis relevant immunosignals uncovering amino acids utilization related risk factors guide artificial intelligence-based precision medicineFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1079566
2
Haiwei Zhang, Juan Zhao, Wei Yang, Zheng Li, Li Gong, Yongsheng Li. Interdisciplinary Cancer Research 2022;  doi: 10.1007/16833_2022_96
3
Elias Kouroumalis, Ioannis Tsomidis, Argryro Voumvouraki. Is There a Place for Somatostatin Analogues for the Systemic Treatment of Hepatocellular Carcinoma in the Immunotherapy Era?Livers 2022; 2(4): 315 doi: 10.3390/livers2040024